Advertisement

Ads Placeholder
Loading...

Galapagos NV

GLPGF•PNK
Healthcare
Biotechnology
$33.27
$0.00(0.00%)
U.S. Market opens in 5h 3m

Galapagos NV (GLPGF) Stock Overview

Explore Galapagos NV’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio5.84
EPS (TTM)$-8.02
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$33.56
3 Months$36.18
1 Year Target$31.50

GLPGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Galapagos NV (GLPGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.84 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
43.24%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
5.02%
6-Month Change
-0.54%
Year-to-Date (YTD) Change
6.33%
1-Year Change
48.59%
3-Year Change
-11.28%
5-Year Change
-57.48%
All-Time (Max) Change
219.90%

Contact Information

https://www.glpg.com
32 1 534 29 00
Generaal De Wittelaan L11 A3, Mechelen, NaN, 2800

Company Facts

7,040 Employees
IPO DateAug 3, 2009
CountryBE
Actively Trading

Frequently Asked Questions